Research
The economic burden of cancer care in Canada: a population-based cost study
Claire de Oliveira, Sharada Weir, Jagadish Rangrej, Murray D. Krahn, Nicole Mittmann, Jeffrey S. Hoch, Kelvin K.W. Chan and Stuart Peacock
January 04, 2018 6 (1) E1-E10; DOI: https://doi.org/10.9778/cmajo.20170144
Claire de Oliveira
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MAPhDSharada Weir
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MADPhilJagadish Rangrej
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MScMMathMurray D. Krahn
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MDMScNicole Mittmann
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MScPhDJeffrey S. Hoch
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MAPhDKelvin K.W. Chan
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MDPhDStuart Peacock
Centre for Addiction and Mental Health (de Oliveira); Institute for Health Policy, Management and Evaluation (de Oliveira, Krahn), University of Toronto; Institute for Clinical Evaluative Sciences (de Oliveira, Rangrej, Krahn, Hoch); Ontario Medical Association (Weir); Toronto Health Economics and Technology Assessment Collaborative (Krahn); Faculty of Pharmacy (Krahn), University of Toronto; Cancer Care Ontario (Mittmann, Chan), Sunnybrook Health Sciences Centre, Toronto, Ont.; University of California, Davis (Hoch), Davis, Calif.; Canadian Centre for Applied Research in Cancer Control (Chan), Cancer Care Ontario, Toronto, Ont.; Canadian Centre for Applied Research in Cancer Control (Peacock), British Columbia Cancer Agency; University of British Columbia (Peacock); Simon Fraser University (Peacock), Vancouver, BC
MScDPhilData supplements
Online appendices
Related Articles
In this issue
Article tools
Respond to this article
The economic burden of cancer care in Canada: a population-based cost study
Claire de Oliveira, Sharada Weir, Jagadish Rangrej, Murray D. Krahn, Nicole Mittmann, Jeffrey S. Hoch, Kelvin K.W. Chan, Stuart Peacock
Jan 2018, 6 (1) E1-E10; DOI: 10.9778/cmajo.20170144
Related Articles
Cited By...
- End-of-life care in cancer and dementia: a nationwide population-based study of palliative care policy changes
- Projection du fardeau du cancer au Canada en 2022
- Projected estimates of cancer in Canada in 2022
- Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer
- Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy
- Patterns of cost-related medication underuse among Canadian adults with cancer: a cross-sectional study using survey data
- Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007-2017